Ionis Pharmaceuticals, Inc.
Modulation of DYRK1B expression
Last updated:
Abstract:
Provided herein are methods, compounds, and compositions for reducing expression of DYRKIB in an animal. Such methods, compounds, and compositions are useful to treat, prevent, delay, or ameliorate a metabolic disease or disorder in an individual in need.
Status:
Grant
Type:
Utility
Filling date:
16 Mar 2017
Issue date:
3 Mar 2020